469 related articles for article (PubMed ID: 25645208)
1. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
Smith JR; Barber KE; Raut A; Aboutaleb M; Sakoulas G; Rybak MJ
J Antimicrob Chemother; 2015; 70(6):1738-43. PubMed ID: 25645208
[TBL] [Abstract][Full Text] [Related]
2. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
[TBL] [Abstract][Full Text] [Related]
3. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
[TBL] [Abstract][Full Text] [Related]
5. Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an
Jahanbakhsh S; Singh NB; Yim J; Kebriaei R; Smith JR; Lev K; Tran TT; Rose WE; Arias CA; Rybak MJ
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094136
[No Abstract] [Full Text] [Related]
6. In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
Hindler JA; Wong-Beringer A; Charlton CL; Miller SA; Kelesidis T; Carvalho M; Sakoulas G; Nonejuie P; Pogliano J; Nizet V; Humphries R
Antimicrob Agents Chemother; 2015 Jul; 59(7):4279-88. PubMed ID: 25963982
[TBL] [Abstract][Full Text] [Related]
7. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
Carter GP; Harjani JR; Li L; Pitcher NP; Nong Y; Riley TV; Williamson DA; Stinear TP; Baell JB; Howden BP
J Antimicrob Chemother; 2018 Jun; 73(6):1562-1569. PubMed ID: 29518208
[TBL] [Abstract][Full Text] [Related]
8. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
Sakoulas G; Bayer AS; Pogliano J; Tsuji BT; Yang SJ; Mishra NN; Nizet V; Yeaman MR; Moise PA
Antimicrob Agents Chemother; 2012 Feb; 56(2):838-44. PubMed ID: 22123698
[TBL] [Abstract][Full Text] [Related]
9. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
10. Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE.
Werth BJ; Barber KE; Tran N; Nonejuie P; Sakoulas G; Pogliano J; Rybak MJ
J Antimicrob Chemother; 2015 Feb; 70(2):489-93. PubMed ID: 25304643
[TBL] [Abstract][Full Text] [Related]
11. Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium.
Sakoulas G; Rose W; Nonejuie P; Olson J; Pogliano J; Humphries R; Nizet V
Antimicrob Agents Chemother; 2014; 58(3):1494-500. PubMed ID: 24366742
[TBL] [Abstract][Full Text] [Related]
12. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
Kebriaei R; Stamper KC; Singh KV; Khan A; Rice SA; Dinh AQ; Tran TT; Murray BE; Arias CA; Rybak MJ
J Infect Dis; 2020 Oct; 222(9):1531-1539. PubMed ID: 32514561
[TBL] [Abstract][Full Text] [Related]
14. Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation
Kunz Coyne AJ; Stamper K; El Ghali A; Kebriaei R; Biswas B; Wilson M; Deschenes MV; Tran TT; Arias CA; Rybak MJ
Microbiol Spectr; 2023 Aug; 11(4):e0034023. PubMed ID: 37338375
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Vouillamoz J; Moreillon P; Giddey M; Entenza JM
J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
[TBL] [Abstract][Full Text] [Related]
16. Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant
Barber KE; Shammout Z; Smith JR; Kebriaei R; Morrisette T; Rybak MJ
Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438947
[TBL] [Abstract][Full Text] [Related]
17. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
Wu T; Meyer K; Harrington AT; Danziger LH; Wenzler E
J Antimicrob Chemother; 2019 May; 74(5):1300-1305. PubMed ID: 30753495
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faecium.
Lorenzo MP; Kidd JM; Jenkins SG; Nicolau DP; Housman ST
J Antimicrob Chemother; 2019 Aug; 74(8):2269-2273. PubMed ID: 31050740
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
Sader HS; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]